Plus, the latest news about Alpha-gal syndrome (AGS) cases and the FDA approval of the second over-the-counter naloxone nasal spray, RiVive.
Summer COVID surge, red meat allergy from ticks, and new FDA approved OTC naloxone …
Share This Story, Choose Your Platform!
About the Author:
